RXO (NYSE:RXO – Get Free Report) had its price objective decreased by stock analysts at Citigroup from $30.00 to $23.00 in a report released on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Citigroup’s target price would suggest a potential upside of 5.55% from the stock’s current price.
Other analysts have also issued reports about the stock. Weiss Ratings upgraded shares of RXO from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 4th. Stephens upgraded shares of RXO to a “hold” rating in a research report on Wednesday, July 8th. Truist Financial dropped their price target on shares of RXO from $30.00 to $28.00 and set a “buy” rating on the stock in a research note on Friday. Deutsche Bank Aktiengesellschaft set a $30.00 price objective on shares of RXO in a research report on Friday. Finally, Stifel Nicolaus set a $31.00 target price on RXO in a report on Friday. Five equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $23.85.
View Our Latest Stock Report on RXO
RXO Stock Performance
RXO (NYSE:RXO – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. RXO had a negative return on equity of 1.16% and a negative net margin of 1.83%.The business had revenue of $1.77 billion during the quarter, compared to the consensus estimate of $1.63 billion. During the same period in the previous year, the company posted $0.04 EPS. The business’s quarterly revenue was up 25.0% compared to the same quarter last year. As a group, research analysts predict that RXO will post 0.07 earnings per share for the current year.
Hedge Funds Weigh In On RXO
Several large investors have recently made changes to their positions in the business. Orbis Allan Gray Ltd grew its position in shares of RXO by 6.5% during the fourth quarter. Orbis Allan Gray Ltd now owns 34,677,755 shares of the company’s stock worth $438,327,000 after purchasing an additional 2,104,597 shares in the last quarter. Vanguard Group Inc. boosted its stake in RXO by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 17,309,811 shares of the company’s stock worth $218,796,000 after purchasing an additional 93,130 shares during the period. Wellington Management Group LLP boosted its stake in RXO by 7.9% in the 3rd quarter. Wellington Management Group LLP now owns 9,998,681 shares of the company’s stock worth $153,780,000 after purchasing an additional 735,810 shares during the period. State Street Corp grew its holdings in RXO by 3.7% during the 4th quarter. State Street Corp now owns 6,370,232 shares of the company’s stock valued at $80,520,000 after buying an additional 230,053 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in RXO by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 3,876,488 shares of the company’s stock valued at $49,008,000 after buying an additional 18,110 shares in the last quarter. 92.73% of the stock is currently owned by hedge funds and other institutional investors.
Key RXO News
Here are the key news stories impacting RXO this week:
- Positive Sentiment: RXO reported adjusted earnings of $0.06 per share, above the $0.04 consensus estimate and up from $0.04 a year earlier. Revenue increased 25% year over year to $1.77 billion, surpassing the $1.63 billion estimate. Market Share Gains and Improved Profitability Drive Strong Second-Quarter Results for RXO
- Positive Sentiment: Management highlighted profitable volume growth, including 2% truckload volume growth in brokerage, market-share gains and another sequential record for gross profit per load. The results suggest RXO is improving execution ahead of its previously stated expectations. RXO 2026 Q2 Results Earnings Call Presentation
- Positive Sentiment: Citizens JMP upgraded RXO from “market perform” to “outperform” and assigned a $30 price target. Truist maintained a “buy” rating while reducing its target from $30 to $28, signaling continued confidence despite more cautious valuation assumptions. Analyst Ratings via Benzinga
- Neutral Sentiment: Coverage characterized the quarter as mixed: strong revenue and earnings were offset by questions about margin performance and the pace of recovery in certain freight markets. RXO’s Mixed Q2 Results
- Negative Sentiment: RXO continues to report a negative net margin of 1.83% and negative return on equity of 1.16%. Analysis also pointed to margin pressure, while slower Class 8 truck orders could weigh on freight demand and industry conditions. What Drove RXO’s Margin Drop
RXO Company Profile
RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Further Reading
- Five stocks we like better than RXO
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
